| Company Name | Amount Raised | Type of Fundraise | Country | Date |
| Private Company Financings |
| Third Arc Bio | $52 million | Series A extension | US | 4 February |
| Angitia Biopharmaceuticals | $130 million | Series D | US | 5 February |
| Galux | $29 million | Series B | US | 9 February |
| Aerska | $39 million | Series A | Ireland | 9 February |
| QuantX Biosciences | $85 million | Series B | US | 9 February |
| ILiAD Biotechnologies | $115 million | Series B | US | 10 February |
| Starget Pharma | $18 million | Series A | US | 18 February |
| Korsana Biosciences | $175 million | Series A | US | 18 February |
| Altesa BioSciences | $75 million | Series B | US | 19 February |
| Slate Medicines | $130 million | Series A | US | 24 February |
| BreezeBio | $60 million | Series B | US | 25 February |
| Atrium Therapeutics | $270 million | N/A | US | 27 February |
| Public Company Financings |
| Vaxcyte | $632.5 million | Public offering | US | 2 February |
| Veradermics | $256.3 million | Public offering | US | 3 February |
| Adlai Nortye | $140 million | Private placement | US | 3 February |
| LB Pharmaceuticals | $100 million | Private placement | US | 5 February |
| Eikon Therapeutics | $381 million | Public offering | US | 9 February |
| Sutro Biopharma | $110 million | Public offering | US | 10 February |
| Galecto | $275 million | Public offering | Denmark | 10 February |
| Cascade Pharmaceuticals | $72.3 million | Public offering | China | 11 February |
| Coherus Oncology | $50.1 million | Public offering | US | 12 February |
| Opus Genetics | $25 million | Private placement | US | 13 February |
| Immunic | $400 million | Private placement | US | 13 February |
| Sensei Biotherapeutics | $200 million | Private placement | US | 18 February |
| Candel Therapeutics | $100 million | Public offering | US | 19 February |